• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 478060 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1417012751 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1417012751 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Possible Bearish Inside Day Candle Pattern Detected for GlaxoSmithKline (NYSE:GSK)

Published on Mon, 04/15/2013 - 07:27
By Peter Chu

Analyzing the price chart for GlaxoSmithKline (NYSE:GSK) has revealed a potential bearish inside day candle pattern. Yesterday's price range of $48.15 and $48.50 is within the prior day's high and low of the day. This trading action often signifies indecision by bulls and bears to drive prices higher or lower and often implies a possible change in trend. Owners of GlaxoSmithKline may want to consider a possible hedge in the event a pullback occurs. Look for confirmation in the next few trading days.

GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders

In the past 52 weeks, GlaxoSmithKline share prices have been bracketed by a low of $41.68 and a high of $48.55 and closed yesterday at $48.47, 16% above that low price. The 200-day and 50-day moving averages have moved 0.11% higher and 0.61% higher over the past week, respectively.

GlaxoSmithKline (NYSE:GSK) is currently priced 0.2% above its average consensus analyst price target of $48.39. The stock should find initial support at its 50-day moving average (MA) of $45.68 and further support at its 200-day MA of $45.26.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Analyst Rating In Review: Western Union ...

A week ago, Standpoint Research downgraded Western Union from Buy to Hold. The shares ...

Shares of Hertz Global Rank the Highest ...

We looked at the Trucking industry and measured relative performance to find the top st ...

First Niagara Financial Group has the Be...

Below are the top five companies in the Thrifts & Mortgage Finance industry as measured ...

AK Steel Holding is Among the Companies ...

Here are the top 5 stocks in the Steel industry ranked by performance. We compiled the ...

Build-A-Bear Workshop is Among the Compa...

We looked at the Specialty Stores industry and measured relative performance to find th ...

Relatively Good Performance Detected in ...

Below are the top five companies in the Specialized REITs industry as measured by relat ...

Encore Capital Group is Among the Compan...

We looked at the Specialized Finance industry and measured relative performance to find ...

Shares of Dr Pepper Snapple Rank the Hig...

We looked at the Soft Drinks industry and measured relative performance to find the top ...